Explore

Insider trades Fund holdings Congress trades Federal contracts

Yours

Watchlist Alerts Saved Ask Claude or ChatGPT

Create a free account Sign in

Search/

Search/

Loading…

Bridgewater Associates disclosed an increased position in DGX for Q2 2026 | OQRO

Fund holdings

Bridgewater Associates disclosed an increased position in DGX for Q2 2026

Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026

DGXQuest DiagnosticsDGX

3,756
Shares reported · +285 vs prior quarter: 0.00%
Disclosed portfolio weight: $796K
Reported value

Why it stands out

From a 13F filed Aug 14, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 13F-HR — Institutional Investment Manager Holdings Report

All the details

Dates, kept separate

Transaction date: Not disclosed
Holdings as of (quarter end): Jun 30, 2026
Filed with the SEC: Aug 14, 2026

Increased0.00% of disclosed portfolio+8% shares

Context

Change vs prior quarter

Increased

Compared with the manager's Q1 2026 13F

Shares, prior quarter

3,471

Shares, this quarter

3,756

Share-count change

+8.2%

Share count drives classification; reported value also moves with price

Ask Claude or ChatGPT about these filings. Connect OQRO in a minute, then ask things like “which insiders bought this week?”

Weight in disclosed 13F portfolio

0.00%

Within the filing's reported positions, not the manager's total assets

Tracked managers with the same change

1

For Q2 2026

Source receipt

Record ID: 0001350694-26-000003
Filed / recorded: Aug 14, 2026, 8:08 PM UTC
Added to OQRO: Oct 2, 2026, 9:25 AM UTC
Parser: 13f-infotable-v1
Data quality: Verified: identifiers matched exactly
Issuer (as reported): QUEST DIAGNOSTICS INC
CUSIP: 74834L100
Quarter end: Jun 30, 2026
Prior quarter end: Mar 31, 2026
Shares, prior: 3,471
Shares, current: 3,756
Reported value: $796,084
Split-adjusted: No

Around the same time

CEO sold ~$2.43M of Quest Diagnostics

Scheduled in advance5w ago

5w ago

23KShares · @ $112.17

Derivative exercise or conversion — not an open-market buy.

Why it stands out Official record

Officer sold ~$3.89M of Quest Diagnostics

Scheduled in advance5w ago